by Scott Larrivee | Nov 27, 2023 | Industry News
From MedicalXpress: A team of researchers has developed a new method that suppresses the distribution of drugs to healthy tissues and also rapidly removes the drugs once distributed in the body, which could improve the accuracy of imaging diagnosis of difficult...
by Scott Larrivee | Sep 28, 2023 | News
NEW YORK – September 28, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October. William Blair Virtual Radiopharma Conference...
by Scott Larrivee | Aug 22, 2023 | News
With many now expecting radiopharmaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
by Scott Larrivee | Jul 20, 2023 | News
VALENCIA, Calif. – July 20, 2023 – Nusano, Inc., a company working to stabilize and enable the production of cancer-fighting radioisotopes, today announced participation in two conferences in July 2023. Nusano CEO Chris Lowe will present an overview of the company’s...
by Scott Larrivee | May 15, 2023 | News, Utah
SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals,...
